Indrayani Biotech share price
BSE: 526445Agricultural Food & other ProductsSmall Cap
Indrayani Biotech Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1994
Last close ₹7.81down ₹0.41 (4.99%)
Share price at the BSE close on 29 Oct 2026. Previous close ₹8.22.
29 Oct: open ₹8.22, high ₹8.22, low ₹7.81
52-week range of traded prices to 29 Oct 2026
₹6.10Low, 19 Mar 2026₹16.47High, 6 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹36 Cr3,322nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Owners' profit not stated
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.49
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 1.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.26
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 29,424
Results
Standalone, as consolidated accounts are on record for only 6 of the last ten years; ₹ crore.Indrayani Biotech quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +14.6%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- –
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹4.15 Crup 1.80%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹0.15 Crup 517.45%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 3.5%
Revenue by quarter
Peak revenue ₹9.51 Cr, quarter to Sep 2024; lowest ₹4.08 Cr, quarter to Mar 2026
Net profit by quarter, a loss in red
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.51 | 8.19 | 9.28 | 6.69 | 5.93 | 5.20 | 4.08 | 4.15 |
| Net profit | 0.10 | 0.11 | 0.20 | 0.13 | 0.47 | 0.08 | 0.02 | 0.15 |
| Net margin | 1.0% | 1.3% | 2.2% | 1.9% | 7.9% | 1.5% | 0.6% | 3.5% |
Standalone. The last eight quarters. The latest is shaded.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹22 Crdown 42.02%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹0.70 Crdown 51.62%
- Net margin
- 3.2%
Revenue by year
Peak revenue ₹74 Cr, year to Mar 2023; lowest ₹21 Cr, year to Mar 2021
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 3 of the 10 years shown
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | – | – | 47.0 | 49.9 | 21.0 | 58.0 | 74.5 | 62.3 | 37.8 | 21.9 |
| Net profit | −0.1 | −0.1 | 0.0 | 0.8 | −10.9 | 4.2 | 5.1 | 1.5 | 1.4 | 0.7 |
| Net margin | – | – | 0.1% | 1.6% | −51.8% | 7.3% | 6.8% | 2.3% | 3.8% | 3.2% |
Standalone. Years to March. The latest is shaded.
Business segments
In the year to Mar 2026 the company reports one business segment, FOOD AND BEVERAGES, which carries all its revenue.
Valuation
Today, against the company's own history. Not shown, P/E: a quarter's profit for shareholders does not agree with its own earnings per share. Dividend yield is not shown: no dividend in the years on record.Indrayani Biotech PE ratio and valuation
Price to book
At or below today's level on 3% of 1,100 trading days over the last 5 years.
LowestHighest
Its median3.35Industry median1.81
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −49.3% | −51.6% | +4.8% | 0.0% |
| 3 years | −49.6% | −53.0% | +7.1% | 0.0% |
| 5 years | +2.6% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1, 3 and 5 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Indrayani Biotech competitors and peers
Other Agricultural Products, 93 listed companies, priced on 29 Oct 2026. The table lists the 8 companies closest to Indrayani Biotech in market cap. 3 companies in the table last traded before then: their rows are priced on their last trade.FMCG companies
Indrayani Biotech is not on the chart: it has no P/E or return on equity today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Annvrridhhi VenturesANVRDHI | 45 | 54.00 | 2.42 | +50.8% | +137.4% | 5.7% | 4.7% | 0.00% |
 Dhanlaxmi Crop ScienceDHANLAXMI | 44 | – | 0.97 | – | – | −1.1% | – | 0.00% |
 Vishwas Agri SeedsVISHWAS | 38 | 17.65 | 0.73 | +11.0% | −68.1% | 4.2% | – | 0.00% |
 Times Green Energy (India)TIMESGREEN | 36 | 161.24 | 0.82 | −44.9% | −40.9% | 0.6% | – | 0.00% |
 Dhanwel Hybrid SeedsDHANWEL | 35 | – | – | – | – | – | – | 0.00% |
 Stanbik AgroSTANBIK | 33 | 7.53 | 0.98 | – | – | 13.1% | – | 0.00% |
 Alfavision Overseas (India)ALFAVIO | 33 | 354.58 | 0.77 | – | – | 0.2% | 0.1% | 0.00% |
 Spright AgroSPRIGHT | 32 | – | 0.28 | −75.3% | −196.1% | −17.5% | −20.1% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Indrayani Biotech announcements
Oct 2026
21 Oct · Update On Income Tax Recovery Proceeding
Sep 2026
30 Sep · Sale Of Shares Of Subsidiary Company Under Regulation 30 Of SEBI LODR 2015
30 Sep · Board meeting
Meeting on 7 Oct 2026: quarterly results
Indrayani Biotech share price by year
Each calendar year to 2025.Indrayani Biotech share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 11.31 | −68.8% | 36.43 | 11.30 |
| 2024 | 36.24 | −42.6% | 89.40 | 35.17 |
| 2023 | 63.17 | −16.8% | 82.10 | 49.47 |
| 2022 | 75.95 | +183.9% | 112.25 | 19.05 |
| 2021 | 26.75 | +249.7% | 28.75 | 4.86 |
| 2020 | 7.65 | +16.4% | 9.24 | 6.49 |
| 2019 | 6.57 | −17.9% | 7.60 | 4.75 |
| 2018 | 8.00 | +128.6% | 8.16 | 3.17 |
| 2017 | 3.50 | −57.2% | 9.11 | 3.43 |
| 2016 | 8.17 | −15.8% | 10.22 | 5.08 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before.
Recent sessions
The 9 trading days to 28 Oct 2026, as traded on BSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 28 Oct 2026 | 8.15 | 8.55 | 8.00 | 8.22 | 8.06 | 21,129 |
| 27 Oct 2026 | 7.97 | 8.30 | 7.80 | 8.30 | 7.98 | 11,899 |
| 26 Oct 2026 | 8.30 | 8.30 | 7.93 | 8.01 | 8.03 | 27,482 |
| 23 Oct 2026 | 8.77 | 9.14 | 8.34 | 8.34 | 8.37 | 19,910 |
| 22 Oct 2026 | 8.50 | 9.09 | 8.50 | 8.77 | 8.76 | 36,635 |
| 21 Oct 2026 | 8.60 | 8.68 | 8.41 | 8.68 | 8.60 | 91,451 |
| 19 Oct 2026 | 8.06 | 8.40 | 8.06 | 8.27 | 8.25 | 16,151 |
| 16 Oct 2026 | 7.87 | 8.20 | 7.66 | 8.15 | 7.93 | 43,917 |
| 15 Oct 2026 | 8.39 | 8.40 | 7.98 | 8.02 | 8.01 | 97,983 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Rights issue and open offer history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 28 Apr 2026 | Rights issue | – | Shareholders were offered new shares. Noted, not adjusted for. |
| 24 Sep 2010 | Scheme of arrangement | – | A scheme of arrangement is a court-approved plan that merges, splits off or reorganises parts of a company. One took effect here and the price moved by a fifth or more between two trading sessions. What shareholders received is not on record, so earlier prices are not shown. |
Where an event has no factor that can be worked out, the chart leaves out the closes before it. Any other event is noted and not adjusted for.
Company details
- BSE code
- 526445
- ISIN
- INE007C01021
- Industry
- Agricultural Food & other Products
- Website
- www.indrayani.com
- CIN
- L40100TN1992PLC129301
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1992
- Registered office
- Block 1, Module No.33,, 3rd Floor, SIDCO Electronic Complex, Thiru-Vi-Ka Industrial Estate, Guindy, Chennai 600032, Tamil Nadu
- Share registrar
- MUFG Intime India Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments